130 related articles for article (PubMed ID: 37873168)
1. Allosteric activation of VCP, a AAA unfoldase, by small molecule mimicry.
Jones NH; Liu Q; Urnavicius L; Dahan NE; Vostal LE; Kapoor TM
bioRxiv; 2023 Oct; ():. PubMed ID: 37873168
[TBL] [Abstract][Full Text] [Related]
2. Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry.
Jones NH; Liu Q; Urnavicius L; Dahan NE; Vostal LE; Kapoor TM
Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2316892121. PubMed ID: 38833472
[TBL] [Abstract][Full Text] [Related]
3. A Non-Competitive Inhibitor of VCP/p97 and VPS4 Reveals Conserved Allosteric Circuits in Type I and II AAA ATPases.
Pöhler R; Krahn JH; van den Boom J; Dobrynin G; Kaschani F; Eggenweiler HM; Zenke FT; Kaiser M; Meyer H
Angew Chem Int Ed Engl; 2018 Feb; 57(6):1576-1580. PubMed ID: 29271116
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase.
Zalk R; Shoshan-Barmatz V
Biochem J; 2003 Sep; 374(Pt 2):473-80. PubMed ID: 12747802
[TBL] [Abstract][Full Text] [Related]
5. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
Wang Q; Song C; Yang X; Li CC
J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
[TBL] [Abstract][Full Text] [Related]
6. AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation.
Caffrey B; Zhu X; Berezuk A; Tuttle K; Chittori S; Subramaniam S
J Biol Chem; 2021 Oct; 297(4):101187. PubMed ID: 34520757
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases.
Valimehr S; Sethi A; Shukla M; Bhattacharyya S; Kazemi M; Rouiller I
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238606
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the AAA
Rao MV; Williams DR; Cocklin S; Loll PJ
J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM of the pathogenic VCP variant R155P reveals long-range conformational changes in the D2 ATPase ring.
Mountassif D; Fabre L; Zaid Y; Halawani D; Rouiller I
Biochem Biophys Res Commun; 2015 Dec; 468(4):636-41. PubMed ID: 26549226
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide dependent motion and mechanism of action of p97/VCP.
DeLaBarre B; Brunger AT
J Mol Biol; 2005 Mar; 347(2):437-52. PubMed ID: 15740751
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
[TBL] [Abstract][Full Text] [Related]
12. A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration.
Suvarna K; Honda K; Muroi M; Kondoh Y; Osada H; Watanabe N
J Biol Chem; 2019 Mar; 294(9):2988-2996. PubMed ID: 30610116
[TBL] [Abstract][Full Text] [Related]
13. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.
Hänzelmann P; Schindelin H
J Biol Chem; 2011 Nov; 286(44):38679-38690. PubMed ID: 21914798
[TBL] [Abstract][Full Text] [Related]
14. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
15. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
16. Cryo-electron microscopy structures of VCP/p97 reveal a new mechanism of oligomerization regulation.
Yu G; Bai Y; Li K; Amarasinghe O; Jiang W; Zhang ZY
iScience; 2021 Nov; 24(11):103310. PubMed ID: 34765927
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP).
Kim SJ; Cho J; Song EJ; Kim SJ; Kim HM; Lee KE; Suh SW; Kim EE
J Biol Chem; 2014 May; 289(18):12264-74. PubMed ID: 24610782
[TBL] [Abstract][Full Text] [Related]
18. The Interplay of Cofactor Interactions and Post-translational Modifications in the Regulation of the AAA+ ATPase p97.
Hänzelmann P; Schindelin H
Front Mol Biosci; 2017; 4():21. PubMed ID: 28451587
[TBL] [Abstract][Full Text] [Related]
19. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
20. Structural insights of the p97/VCP AAA+ ATPase: How adapter interactions coordinate diverse cellular functionality.
Braxton JR; Southworth DR
J Biol Chem; 2023 Nov; 299(11):105182. PubMed ID: 37611827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
